Zdrowie i gospodarka · 22/06/2010

FDA Announces Guidance for Industry on Lupus Nephritis Treatment

The Food and Drug Administration (FDA) has released a guidance document providing recommendations for developing medical products to treat lupus nephritis, a complication of systemic lupus erythematosus (SLE), and finalizing a draft guidance on the topic.